Skip to content
value.today

Morphogenesis Inc.

🇺🇸 Tampa, Florida, USABiotechnologyFounded 2023
Total raised
$22 M
5 rounds on record
Latest round
$2 M
Dec 2023
First round on record
Aug 2017
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Morphogenesis Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2023$2 MNo. 5Under $2 million

Morphogenesis Inc.: Raise no. 5, Dec 2023

Investors in this round

8 investors had bought by the notice of Dec 27, 2023: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $15 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$133,200
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Dearborn · Executive Officer
  • James Bianco · Executive Officer, Director
  • Alan List · Director
  • George Ng · Director
  • James Manuso · Director
  • Kiran Patel · Director
  • Michael Lawman · Director
  • Patricia Lawman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company LLC (CRD 5670) · Portland, OregonSold in all US states

Remarks in the notice

  • On fees: “"Paulson Investment Company, LLC (""Paulson"") will be paid a cash placement fee equal to 6% of gross proceeds of Offering. Issuer will also issue to Paulson a number of shares of Common Stock equal to 2% of the gross proceeds of Offering divided by 1.5."”

Signed by Dan Dearborn, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 27, 2023. Read the notice at the SEC.

debt, optionsSEC
Jun 2022$9 MNo. 4$2 to $10 million

Morphogenesis Inc.: Raise no. 4, Jun 2022

Investors in this round

2 investors had bought by the notice of Jul 11, 2022: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $20 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Dan Dearborn · Executive Officer
  • James Bianco · Executive Officer, Director
  • George C. Ng · Director
  • Kiran C. Patel · Director
  • Michael C. Lawman · Director
  • Patricia C. Lawman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dan Dearborn, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 11, 2022. Read the notice at the SEC.

equitySEC
Oct 2021$5 MNo. 3$2 to $10 million

Morphogenesis Inc.: Raise no. 3, Oct 2021

Investors in this round

4 investors had bought by the notice of Nov 19, 2021: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • James Bianco · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dan Dearborn, Cfo. Source: SEC Form D, newest notice filed Nov 19, 2021. Read the notice at the SEC.

equitySEC
Oct 2020$4 MNo. 2$2 to $10 million

Morphogenesis Inc.: Raise no. 2, Oct 2020

Investors in this round

39 investors had bought by the notice of Sep 29, 2021: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $11 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$304,355
Finders' fees
none
Paid to its own people
$378,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Daniel Dearborn · Executive Officer
  • James Bianco · Executive Officer, Director
  • George Ng · Director
  • Kiran Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company, LLC (CRD 5670) · Lake Oswego, OregonSold in CA, CT, FL, HI, IL, IN, MI, NC, NJ, NY, OH, PR, TN, TX, VA

Remarks in the notice

  • On the use of proceeds: “Salaries for 3 executive officers assuming the entire $10,000,000 is raised.”

Signed by Dan Dearborn, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Sep 29, 2021. Read the notice at the SEC.

equitySEC
Aug 2017$3 MNo. 1$2 to $10 million

Morphogenesis Inc.: Raise no. 1, Aug 2017

Investors in this round

40 investors had bought by the notice of Jan 12, 2018: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $15 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$1,200,000
Finders' fees
none
Paid to its own people
$376,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Florida

People named in the notice

  • Michael John Lawman · Executive Officer, Director
  • Patricia Dianne Lawman · Executive Officer, Director
  • Scott Dianne Slayton · Executive Officer
  • David John Bergmann · Director
  • David John Lawman · Director
  • Grahame John Cook · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company, LLC (CRD 5670) · broker-dealer Skyway Capital Markets, LLC (CRD 124630) · Chicago, IllinoisSold in FL, GA, MD, NY, VA
  • Skyway Capital Markets, LLC (CRD 124630) · broker-dealer Paulson Investment Company, LLC (CRD 5670) · Tampa, FloridaSold in FL, GA, MD, NY, VA

Remarks in the notice

  • On fees: “Assuming sale of entire offering. Plus warrants to purchase 3,750,000 shares at a purchase price of $0.52/share.”
  • On the use of proceeds: “Figure includes 2018 salaries for Patricia Lawman and Michael Lawman and consulting fees for Scott Slayton.”

Signed by Patricia D Lawman, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 12, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Morphogenesis Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2023).

    SEC Form D · Dec 2023

  • Revenue range over time, as stated in its notices: revenue of up to $1 million in 2018; no revenue in 2021.

    SEC Form D (revenue range) · Nov 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2023

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Morphogenesis Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 40 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Morphogenesis Inc.
NameRoleNamed in
Dan DearbornExecutive officerDec 2023
James BiancoExecutive officerDec 2023
Daniel DearbornExecutive officerSep 2021
Michael LawmanExecutive officerDec 2020
Michael John LawmanExecutive officerJan 2018
Patricia Dianne LawmanExecutive officerJan 2018
Scott Dianne SlaytonExecutive officerJan 2018
Alan ListDirectorDec 2023
George NgDirectorDec 2023
James BiancoDirectorDec 2023
James ManusoDirectorDec 2023
Kiran PatelDirectorDec 2023
Michael LawmanDirectorDec 2023
Patricia LawmanDirectorDec 2023
George C. NgDirectorJul 2022
Kiran C. PatelDirectorJul 2022
Michael C. LawmanDirectorJul 2022
Patricia C. LawmanDirectorJul 2022
David John BergmannDirectorJan 2018
David John LawmanDirectorJan 2018
Grahame John CookDirectorJan 2018
Michael John LawmanDirectorJan 2018
Patricia Dianne LawmanDirectorJan 2018